239 results on '"Kocakaya, Derya"'
Search Results
2. Stem cell treatment reduces T cell apoptosis in COPD patients with chronic bronchitis but not with emphysema
3. Is Pulmonary Capillary Wedge Pressure a Reliable Indicator of Postcapillary Pulmonary Hypertension?
4. Angiographic findings of pulmonary arterial involvement in Behcet's Disease: Do they correlate with symptoms and acute phase response?
5. Diagnostic performance of lactate dehydrogenase (LDH) isoenzymes levels for the severity of COVID-19
6. Right Ventricular Energy Failure Predicts Mortality in Patients With Pulmonary Hypertension
7. Bacterial Pneumonia During Pregnancy
8. Treatment of Respiratory Infections in Pregnant Patients: Overview
9. The angiogenic gene profile of pulmonary endarterectomy specimens: Initial study
10. Balloon Pulmonary Angioplasty in Patients With Inoperable or Recurrent/Residual Chronic Thromboembolic Pulmonary Hypertension: A Single-Centre Initial Experience
11. The Association of Depression with Obstructive Sleep Apnea in Patients with Cystic and Non-Cystic Fibrosis Bronchiectasis.
12. Impact of Anxiety, Depression, and Coping Strategies on Health-Related Quality of Life in Patients with Cystic Fibrosis.
13. New grading system for post-COVID-19 pulmonary fibrosis based on computed tomography findings
14. FDG PET/CT Features of Polysaccharide-Based Hemostatic Agent: Chronic Inflammatory Changes Can Mimic Metastatic Lesions
15. Clinical Pharmacist-Led Medication Review in Hospitalized Confirmed or Probable Patients with COVID-19 During the First Wave of COVID-19 Pandemic.
16. CLINICAL PHARMACIST-LED MEDICATION REVIEW IN HOSPITALIZED CONFIRMED OR PROBABLE PATIENTS WITH COVID-19 DURING THE FIRST WAVE OF COVID-19 PANDEMIC
17. Angiographic findings of pulmonary arterial involvement in Behcet's Disease: Do they correlate with symptoms and acute phase response?
18. The relationship between the preoperative pulmonary function test and DLCO values and the anatomical classification of thrombus in patients who underwent pulmonary endarterectomy with the diagnosis of chronic thromboembolic pulmonary hypertension.
19. Late Breaking Abstract - Association with changes in pulmonary artery diameters and outcomes before, during and after COVID-19 hospitalization:Retrospective Study
20. Anxiety, Depression, and Sleep Disorders After COVID-19 Infection
21. Results of surgical treatment of pulmonary artery sarcomas: Does histology affect survival?
22. Real-life data of direct anticoagulant use, bleeding risk and venous thromboembolism recurrence in chronic thromboembolic pulmonary hypertension patients: an observational retrospective study
23. Increased D-dimer is associated with disease progression and increased mortality in Turkish COVID-19 patients
24. Are Guideline-recommended Risk Classification Schemes in Pulmonary Hypertension Adequately Robust to Guide the Real-world Setting?
25. Pulmonary Hypertension Classification using Artificial Intelligence and Chest X-Ray:ATA AI STUDY-1
26. Pre-existing Immunocompromised Status as a Preventer of Mortality in COVID-19 Patients: Friend or Foe?
27. The impact of cystic fibrosis- and noncystic fibrosis-bronchiectasis on pulmonary artery wall thickness and right heart functions assessed by speckle-tracking echocardiography
28. Lung cavitation as a long-term imaging pattern of covid-19
29. Surgical Treatment of Another Sequalae of COVID-19: Post-COVID CTEPH
30. Risk factors for bronchoscopic complications in patients over 75 years of age
31. Diagnostic performance of lactate dehydrogenase (LDH) isoenzymes levels for the severity of COVID-19
32. Relationship of muscle thickness, strength, and diaphragm function in adults with cystic fibrosis
33. Radial arterial thrombosis in COVID-19: A case report
34. Pulmonary arterial wall thickness increased in Behçet’s disease patients with major organ involvement: Is it a sign of severity?
35. Radiological comparison of the Wuhan and B.1.1.7 variant COVID-19 infection; are there any differences in chest CT scans?
36. Relationship of muscle thickness, strength, and diaphragm function in adults with cystic fibrosis.
37. Factors Associated with 28-day Critical Illness Development During the First Wave of COVID-19.
38. The Impact of Cystic Fibrosis- and Noncystic Fibrosis-Bronchiectasis on Pulmonary Artery Wall Thickness and Right Heart Functions Assessed by Speckle-Tracking Echocardiography.
39. KF ve KF dışı bronşektazi hastalarında obstrüktif uyku apnesinin depresyon üzerine etkisi
40. Kistik Fibrozis ve KF Dışı Bronşektazi Hastalarında Obstrüktif Uyku Apne Sıklığı VeKlinik Bulgularla İlişkisi
41. Akciğer Kavitasyonu COVID-19'un Uzun Dönem Radyolojik Görüntüleme BulgusuOlabilir mi?
42. Pulmonary hypertension classification based on machine learning using standart chest x-ray : ata artificial intelligence study-1
43. PULMONARY HYPERTENSION CLASSIFICATION BASED ON MACHINE LEARNING USING STANDART CHEST X-RAY:ATA ARTIFICIAL INTELLIGENCE STUDY-1
44. The effectiveness of additional long-term use of bottle-positive expiratory pressure in chronic obstructive pulmonary disease: A single-blind, randomized study
45. The role of procalcitonin as a biomarker for acute pulmonary exacerbation in subjects with cystic fibrosis and non-cystic fibrosis bronchiectasis
46. Nutrition risk assessed by Nutritional Risk Screening 2002 is associated with in‐hospital mortality in older patients with COVID‐19
47. Hastanede yatan kesin veya olası COVID-19 hastalarında klinik eczacı öncülüğünde yürütülen ilaç incelemesi hizmeti
48. Bacterial Pneumonia During Pregnancy
49. Change in pulmonary arterial compliance and pulmonary pulsatile stress after balloon pulmonary angioplasty
50. Pulmonary arterial wall thickness increased in Behçet's disease patients with major organ involvement: Is it a sign of severity?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.